Direct Costs of Healthcare for Children with Type 1 Diabetes Using a CGM System : A Health Economic Analysis of the VIDIKI Telemedicine Study in a German Setting
Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany..
AIMS: The Virtual Diabetes Outpatient Clinic for Children and Adolescents (VIDIKI) study was a 6-month quasi-randomized, multicentre study followed by an extension phase to evaluate the effects of monthly video consultations in addition to regular care. A health economic analysis was conducted to assess the direct costs.
METHODS: The cost data of 240 study participants (1-16 years of age) with type 1 diabetes who were already using a continuous glucose monitoring system were collected in the first 6 months of the study. The intervention group (IG) received monthly video consultations plus regular care, and the waiting control group (WG) received only regular care. Cost data were collected for a comparable anonymized group of children from the participating health insurance companies during the 6-month period before the study started (aggregated data group [AG]).
RESULTS: Cost data were analysed for the AG (N=840) 6 months before study initiation and those for the study participants (N=225/240). Hospital treatment was the highest cost category in the AG. There was a cost shift and cost increase in the IG and WG, whereby diabetes supplies were the highest cost category. The mean direct diabetes-associated 6-month costs were € 4,702 (IG) and € 4,936 (WG).
CONCLUSION: The cost development within the cost collection period over two years possibly reflects the switch to higher-priced medical supplies. Video consultation as an add-on service resulted in a small but nonsignificant reduction in the overall costs.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:130 |
|---|---|
| Enthalten in: |
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association - 130(2022), 9 vom: 24. Sept., Seite 614-620 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Frielitz, Fabian Simon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Blood Glucose |
|---|
| Anmerkungen: |
Date Completed 20.09.2022 Date Revised 20.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1708-3134 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM335150306 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM335150306 | ||
| 003 | DE-627 | ||
| 005 | 20231225225214.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/a-1708-3134 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1117.xml |
| 035 | |a (DE-627)NLM335150306 | ||
| 035 | |a (NLM)34979571 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Frielitz, Fabian Simon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Direct Costs of Healthcare for Children with Type 1 Diabetes Using a CGM System |b A Health Economic Analysis of the VIDIKI Telemedicine Study in a German Setting |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.09.2022 | ||
| 500 | |a Date Revised 20.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany. | ||
| 520 | |a AIMS: The Virtual Diabetes Outpatient Clinic for Children and Adolescents (VIDIKI) study was a 6-month quasi-randomized, multicentre study followed by an extension phase to evaluate the effects of monthly video consultations in addition to regular care. A health economic analysis was conducted to assess the direct costs | ||
| 520 | |a METHODS: The cost data of 240 study participants (1-16 years of age) with type 1 diabetes who were already using a continuous glucose monitoring system were collected in the first 6 months of the study. The intervention group (IG) received monthly video consultations plus regular care, and the waiting control group (WG) received only regular care. Cost data were collected for a comparable anonymized group of children from the participating health insurance companies during the 6-month period before the study started (aggregated data group [AG]) | ||
| 520 | |a RESULTS: Cost data were analysed for the AG (N=840) 6 months before study initiation and those for the study participants (N=225/240). Hospital treatment was the highest cost category in the AG. There was a cost shift and cost increase in the IG and WG, whereby diabetes supplies were the highest cost category. The mean direct diabetes-associated 6-month costs were € 4,702 (IG) and € 4,936 (WG) | ||
| 520 | |a CONCLUSION: The cost development within the cost collection period over two years possibly reflects the switch to higher-priced medical supplies. Video consultation as an add-on service resulted in a small but nonsignificant reduction in the overall costs | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Randomized Controlled Trial | |
| 650 | 7 | |a Blood Glucose |2 NLM | |
| 700 | 1 | |a Eisemann, Nora |e verfasserin |4 aut | |
| 700 | 1 | |a Werner, Kristin |e verfasserin |4 aut | |
| 700 | 1 | |a Hiort, Olaf |e verfasserin |4 aut | |
| 700 | 1 | |a Katalinic, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Lange, Karin |e verfasserin |4 aut | |
| 700 | 1 | |a von Sengbusch, Simone |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association |d 1996 |g 130(2022), 9 vom: 24. Sept., Seite 614-620 |w (DE-627)NLM075292904 |x 1439-3646 |7 nnns |
| 773 | 1 | 8 | |g volume:130 |g year:2022 |g number:9 |g day:24 |g month:09 |g pages:614-620 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1708-3134 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 130 |j 2022 |e 9 |b 24 |c 09 |h 614-620 | ||